Medicines for Malaria Venture - 15th Call for proposals

The Medicines for Malaria Venture (MMV) is a not-for-profit public-private partnership and its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs. MMV asks for projects for its 15th call for proposals. The closing date of Letter of Intend is March 24, 2017.

Proposals in the following three areas are welcome:

• Compounds addressing the key priorities of the malaria eradication agenda;
• Compounds with activity against asexual liver and / or blood stages;
• Novel approaches for screening.

MMV also welcomes requests for support to investigate the mechanism of action compounds: compounds for target indentification. Compounds can be considered for such target identification activities provided that the following terms are acceptable:

• The Plasmodium whole cell EC50 <1uM and the chemical structure can be shared.
• A minimum of 10mgs of compound can be provided to the consortium.
• The ongoing studies and data will be discussed with the compound provider but the consortium have permission to publish (with co-authorship from the provider).